The BSE sensex closed the shop at 56,930UPby 611 points and the Nifty close the day at 16,968 byAdding197 points.
On the Upside: Hindalco, Tatamotors, Divislab, Eichermotor
On the downside- SBI life, Wipro, Grasim, Adaniport
Tech View:-Today we have seen positive gap up up opening following global cues. The BSE Sensex soon jumped to 408 points to quote at 56,727 level and made a high 56,989 for intraday while the Nifty 50 was at 16,891, up 121 points..The Sensex finally ended 612 points higher at 56, 930.The Nifty rallied to a high of 16,971, and eventually ended with a gain of 184 points at 16,955.
Indian Vix decrease around 5.5%, closed @ 16.58.
Sectorial,Nifty realty contributed 3% gain, Where; Nifty small cap 100,Nifty pharma, contributed 2% individually.
Nifty have formed a strong Bullish candle on daily chart, Where; RSI and MACD still giving positive hint, Hence; going forward 17100-17250 will be acting as a resistance and down side 16750-16850 will act as a support.
European & USA markets: @ IST 4:10 European markets were trading atPositive note. Where the Germany’s DAX tradingPositive by 0.10 %, other hand France’s CAC40 indexrunningPositiveby 0.19% where; England’s FTSE100 indexNegativeby 0.02%.
Where; wall street @ IST 04:10 The DOW future contract tradingNegative18 points, S&P 500 Future trading Negative 4 points, Where; Nasdaq100 futureNegative25 points.
Global News Analysis:
LONDON- Britain’s economy grew more slowly than previously thought in the July-September period, before the Omicron variant of the coronavirus posed a further threat to the recovery later in the year, official data showed on Wednesday.
GERMAN- The German government made billions of euros from debt issuance this year thanks to negative interest rates on its securities, according to a letter, seen by Reuters, from Finance Ministry State Secretary Florian Toncar to a left wing lawmaker.
ISRAEL:-Israel is to offer a fourth dose of a COVID-19 vaccine to people older than 60 or with compromised immune systems, and to health workers, as part of a drive to ramp up the shots and outpace the spread of the Omicron variant of the coronavirus.